Clinical trials: Infections, Human Immunodeficiency Virus and Tuberculosis
Tuberculosis, HIV
Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)
The aims of this project are to: 1. To evaluate the pharmacokinetics of first line antituberculosis drugs (isoniazid, rifampicin, pyrazinamide and ethambutol) when applying the 2010 WHO/IUATLD dosing guidelines across pediatric…
- Trial name
- DATiC (NCT01637558)
- Testing
- 8 hourly LPV/r during TB treatment, Nevirapine, Lopinavir/Ritonavir
- Where
- 4 sites in Malawi, South Africa
- Volunteers
- 200 people
- Sponsor
- University of Cape Town